A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: Will cases of psoriasis increase after COVID-19 pandemic?

Dermatol Ther. 2020 Jul;33(4):e13383. doi: 10.1111/dth.13383. Epub 2020 Apr 24.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antiviral Agents / administration & dosage
  • Antiviral Agents / adverse effects
  • COVID-19
  • COVID-19 Drug Treatment
  • Coronavirus Infections / drug therapy*
  • Female
  • Humans
  • Hydroxychloroquine / administration & dosage*
  • Hydroxychloroquine / adverse effects
  • Oseltamivir / administration & dosage*
  • Oseltamivir / adverse effects
  • Pandemics
  • Pneumonia, Viral / drug therapy*
  • Psoriasis / etiology*
  • Psoriasis / pathology

Substances

  • Antiviral Agents
  • Oseltamivir
  • Hydroxychloroquine